Consolidated Statements of Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues
Premiums	$ 45,996	$ 44,237	$ 39,916
Net investment income	973	1,166	1,155
TOTAL REVENUES	247,121	195,265	180,518
Benefits and expenses
Pharmacy and other service costs	182,509	133,801	124,834
Medical costs and other benefit expenses	38,648	36,287	32,184
Selling, general and administrative expenses	14,844	14,822	13,174
Amortization of acquired intangible assets	1,703	1,819	1,876
TOTAL BENEFITS AND EXPENSES	237,704	186,729	172,068
Income from operations	9,417	8,536	8,450
Interest expense and other	(1,435)	(1,446)	(1,228)
Net gain (loss) on sale of businesses	24	(1,499)	1,662
Net investment losses	(2,737)	(78)	(487)
Income before income taxes	5,269	5,513	8,397
TOTAL INCOME TAXES	1,491	141	1,615
Net income	3,778	5,372	6,782
Less: Net income attributable to noncontrolling interests	344	208	78
SHAREHOLDERS' NET INCOME	$ 3,434	$ 5,164	$ 6,704
Shareholders' net income per share
Basic (in dollars per share)	$ 12.25	$ 17.57	$ 21.66
Diluted (in dollars per share)	$ 12.12	$ 17.39	$ 21.41
Pharmacy revenues
Revenues
Revenue from contract with customer	$ 185,362	$ 137,243	$ 128,566
Fees and other revenues
Revenues
Revenue from contract with customer	$ 14,790	$ 12,619	$ 10,881